New Drugs and Therapeutics Update: Libre DUO® 10 Day Continuous Dual Glucose Ketone Monitoring System Prepared by Evan Graber, DO; Edited by Neha Patel, DO On…
Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta, MD and edited…
New Meds and Tech from the D&T Committee: Teplizumab Approval Expanded to Stage 3 Type 1 Diabetes (Ages 8-17) Prepared on behalf of PES Drugs and Therapeutics Committee by…
New Meds and tech from D&T Committee: IMCIVREE® (setmelanotide) injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On March 19, 2026, the FDA approved and…
Teplizumab Approval Expanded to Children >1 Year with Stage 2 Type 1 Diabetes (T1D) Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta, MD…
New Drugs and Therapeutics Update: JUXTAPID® (lomitapide) capsules Prepared by Daniel Mak, MD On March 3rd, 2026, the FDA approved and expanded indication for JUXTAPID (lomitapide) capsules for…
New Drugs and Therapeutics Update: Sogroya® (somapacitan-beco) Injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On February 27th, 2026, the FDA approved Sogroya®…
Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update Written by: Anna Ryabets-Lienhard, DO as part of Drugs and Therapeutics Committee In December 2025, the U.S. Food and…
Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics Written by Anna Ryabets-Lienhard, DO Edited by Neha Patel, DO and Emily Breidbart, MD On February…
New Drugs and Therapeutics Update: DESMODA™ (desmopressin acetate) Oral Solution Prepared by Daniel Mak, MD DESMODA® (desmopressin acetate) Oral Solution On February 25th, 2026, the FDA…